Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Firms / Sonder Capital Management, LLC

Sonder Capital Management, LLC

Institutional venture firmSan Carlos, CAsondercapital.comSEC venture capital fund adviser

Sonder Capital invests in teams and technologies that can transform healthcare in the medical device, diagnostic and healthtech sectors. We are Foundational Investors – we commit our energy and capital early to guide and support companies from inception to acquisition or IPO. We look for big ideas that will change lives.

venture manager, reported GAV $139M across 12 vehicles

Importance
38
elevated
Active deployment
29
moderate
Emerging
0
low
Completeness
88
high
Freshness
100
high
Research priority
10
low
Identity and regulatory footprint
Headquarters
San Carlos, CAadviserinfo.sec.gov
Office address
661 EL CAMINO REAL #202, San Carlos, CA, 94070adviserinfo.sec.gov
Business phone
650-464-1368adviserinfo.sec.gov
SEC adviser type
exempt reporting adviseradviserinfo.sec.gov
SEC exemption claimed
venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
Latest Form ADV
Mar 30, 2026
Private funds reported
8 (8 venture capital funds)adviserinfo.sec.gov
Private fund gross assets
$151Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
business email
closethegap@sondercapital.comsondercapital.compublished by the subject
business email
info@sondercapital.comsondercapital.compublished by the subject
business phone
203-981-6526adviserinfo.sec.govpublished by the subject
business phone
650-464-1368adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
4 observed deals
Stated (the firm’s website)
Sectors
healthcare, medtech, energy
Stages
early
Geography
not stated
Check size
not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation
seed 100%
Stage at first entry
seed 100%
Sectors
Other 25%unknown 25%Biotechnology 25%Other Health Care 25%
lead rate 100%follow-on rate 0%new logos, 12 months 1
Funds and vehicles
12 reported
VehicleTypeVintageLifecycleReported GAVOwnersForm D soldLatest Form D
Sonder SPV J Series B, LPSPV or co-invest vehicle2025 form d first saleNewly closedunknownunknown$4.2M
of $4.2M
Aug 5, 2025
Sonder Futures II, L.P.Fund2024 adv first reportedEarly deployment$44.4M
Mar 29, 2024
51$0
of $225M
Jun 14, 2023
Sonder SPV N Series D, LPSPV or co-invest vehicle2024 form d first saleEarly deploymentunknownunknown$1.8M
of $1.8M
Apr 17, 2024
Sonder Futures II OS, LPFund2024 form d first saleEarly deploymentunknownunknown$8.5M
of $8.5M
Aug 7, 2024
Sonder Spv B, LPSPV or co-invest vehicle2023 form d first saleActive deployment$1.1M
Mar 29, 2024
2$1.1M
of $1.1M
Sep 11, 2023
Sonder Spv II C, LLCSPV or co-invest vehicle2023 form d first saleActive deployment$0
Mar 29, 2024
0$5.0M
of $5.0M
Feb 3, 2023
Sonder Spv N, LPSPV or co-invest vehicle2022 form d first saleActive deployment$7.5M
Mar 29, 2024
97$4.9M
of $4.9M
Jul 27, 2022
Sonder Spv II a, LLCSPV or co-invest vehicle2022 form d first saleActive deployment$2.0M
Mar 29, 2024
3$4.0M
of $4.0M
Jan 4, 2023
Sonder Spv II B, LLCSPV or co-invest vehicle2022 form d first saleActive deployment$1.6M
Mar 29, 2024
2$1.6M
of $1.6M
Mar 31, 2023
Sonder Spv Z, L.P.SPV or co-invest vehicle2021 form d first saleMature$3.3M
Mar 29, 2024
32$3.2M
of $3.2M
Aug 5, 2021
Sonder Futures I Partners Fund, L.P.Fund2020 form d first saleMature$12.2M
Mar 29, 2024
2$15.0M
of $15.0M
Sep 9, 2020
Sonder Futures I, L.P.FundunknownUnknown$67.2M
Mar 29, 2024
62$0
of $80.0M
Jan 30, 2020
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
19 current, 0 departed
Andy Mcgibbon
Operating Advisor
Board or advisory
info@sondercapital.com (published by the subject)FactVenture organization websites (about, team, portfolio, thesis, news pages)
Andy Mcgibbon
Managing Member · since Jan 1, 2020
Managing partner
Investments on record
4 edges, 4 companies, 3 partner-attributed
CompanyRoundRolePartnerRound sizeThis investorDateSource
Cordance MedicalSeed · Seedleadunknown$8.0MunknownNov 24, 2025Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Petal Surgical, Inc.board seatunknown · boardFrederic Moll (strongly supported)unknownunknownAug 29, 2025Inference SEC EDGAR Form D data sets (quarterly)
EndoQuest Robotics, Inc.board seatunknown · boardFrederic Moll (strongly supported)unknownunknownAug 25, 2025Inference SEC EDGAR Form D data sets (quarterly)
VerAvanti Inc.board seatunknown · boardFrederic Moll (strongly supported)unknownunknownMar 10, 2025Inference SEC EDGAR Form D data sets (quarterly)
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
5 relationships from shared deals, counted for the whole firm
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
10 dated events
  1. Mar 29, 2024
    Sonder Spv II C, LLC first reported on Form ADV by Sonder Capital Management, LLC (Venture Capital Fund)
  2. Mar 29, 2024
    Sonder Spv B, LP first reported on Form ADV by Sonder Capital Management, LLC (Venture Capital Fund), GAV $1,088,889
  3. Mar 29, 2024
    Sonder Futures II, L.P. first reported on Form ADV by Sonder Capital Management, LLC (Venture Capital Fund), GAV $44,378,223
  4. Mar 31, 2023
    Sonder Spv II B, LLC first reported on Form ADV by Sonder Capital Management, LLC (Venture Capital Fund), GAV $1,608,325
  5. Mar 31, 2023
    Sonder Spv N, LP first reported on Form ADV by Sonder Capital Management, LLC (Venture Capital Fund), GAV $5,143,667
  6. Mar 31, 2023
    Sonder Spv II a, LLC first reported on Form ADV by Sonder Capital Management, LLC (Venture Capital Fund), GAV $3,999,992
  7. Nov 12, 2021
    Sonder Futures I, L.P. first reported on Form ADV by Sonder Capital Management, LLC (Venture Capital Fund), GAV $105,442,516
  8. Nov 12, 2021
    Sonder Spv Z, L.P. first reported on Form ADV by Sonder Capital Management, LLC (Venture Capital Fund), GAV $3,265,345
  9. Nov 12, 2021
    Sonder Futures I Partners Fund, L.P. first reported on Form ADV by Sonder Capital Management, LLC (Venture Capital Fund), GAV $19,855,861
  10. Nov 12, 2021
    Sonder Capital Management, LLC first filed Form ADV (ERA, venture capital fund adviser exemption)
Classification history
  1. Sep 12, 2026
    Institutional venture firm (confirmed, 95%, cls-1)
    venture manager, reported GAV $139M across 12 vehicles
  2. Sep 12, 2026
    Institutional venture firm (confirmed, 95%, cls-1)
    venture manager, reported GAV $139M across 9 vehicles
Evidence
44 observations from 3 sources
Every observation behind this profile, with its source, date and class
FactValueEffectiveClassSource
Why admittedvc_exemption,vc_funds_reportedMar 30, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC exemption claimedventure_capital_fund_adviserMar 30, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC exemption claimedventure_capital_fund_adviserMar 29, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC adviser typeexempt_reporting_adviserMar 30, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC adviser typeexempt_reporting_adviserMar 29, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
First Form ADV filing2021-11-12Mar 29, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Adv history loadedadv-hist-1Sep 12, 2026FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Latest Form ADV filing2026-03-30Mar 30, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Latest Form ADV filing2024-03-29Mar 29, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC statusERA - ActiveMar 30, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC status effective2021-11-12Mar 30, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Venture share of reported funds1Mar 29, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Business phone650-464-1368Mar 30, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Business phone203-981-6526Mar 29, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
DescriptionSonder Capital invests in teams and technologies that can transform healthcare in the medical device, diagnostic and healthtech sectors. We are Foundational Investors – we commit our energy and capital early to guide and support companies from inception to acquisition or IPO. We look for big ideas that will change lives.
meta description
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
DescriptionSonder Capital invests in teams and technologies that can transform healthcare in the medical device, diagnostic and healthtech sectors. We are Foundational Investors – we commit our energy and capital early to guide and support companies from inception to acquisition or IPO. We look for big ideas that will change lives.
meta description
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
HeadquartersSan Carlos, CAMar 30, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
HeadquartersSan Carlos, CAMar 29, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Office address661 EL CAMINO REAL #202, San Carlos, CA, 94070Mar 30, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Office address661 EL CAMINO REAL #202, San Carlos, CA, 94070Mar 29, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Legal formLimited Liability CompanyMar 30, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Legal formLimited Liability CompanyMar 29, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Portfolio pagehttps://sondercapital.com/portfolio/
0 entries read
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Portfolio pagehttps://sondercapital.com/portfolio/
0 entries read
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Private funds reported8Mar 30, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Private funds reported9Mar 29, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private fund gross assets (reported)$151MMar 30, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Private fund gross assets (reported)$139MMar 29, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Stated sectorshealthcare,medtech,energy
sector words on the home page
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated sectorshealthcare,medtech,energy
sector words on the home page
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated stagesearly
stage words on the home page
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated stagesearly
stage words on the home page
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Team pagehttps://sondercapital.com/people/
14 name/title pairs read
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Team pagehttps://sondercapital.com/people/
10 name/title pairs read
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Venture funds reported8Mar 30, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Venture funds reported9Mar 29, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Websitehttps://sondercapital.com/Mar 30, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Websitehttps://sondercapital.com/Mar 29, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Site titleSonder Capital | Investing in early stage medtech startups
title tag
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Site titleSonder Capital | Investing in early stage medtech startups
title tag
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)